Viewing Study NCT04618393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-23 @ 8:09 PM
Study NCT ID: NCT04618393
Status: TERMINATED
Last Update Posted: 2024-05-21
First Post: 2020-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of EMB-02 in Participants With Advanced Solid Tumors
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I/II View
None Bispecific antibody View
None PD-1 View
None LAG-3 View
None EMB-02 View
None Immuno-oncology View
None dose escalation View
None cohort expansion View
None Neoplasms View
None Neoplasm Metastasis View
None advanced solid tumor View